China Pharma Holdings (CPHI) Notes Payables: 2009-2025
Historic Notes Payables for China Pharma Holdings (CPHI) over the last 10 years, with Sep 2025 value amounting to $1.4 million.
- China Pharma Holdings' Notes Payables rose 348.07% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 348.07%. This contributed to the annual value of $1.1 million for FY2024, which is 0.99% up from last year.
- Latest data reveals that China Pharma Holdings reported Notes Payables of $1.4 million as of Q3 2025, which was up 0.41% from $1.4 million recorded in Q2 2025.
- Over the past 5 years, China Pharma Holdings' Notes Payables peaked at $4.5 million during Q3 2022, and registered a low of $315,428 during Q3 2024.
- In the last 3 years, China Pharma Holdings' Notes Payables had a median value of $1.2 million in 2025 and averaged $1.3 million.
- In the last 5 years, China Pharma Holdings' Notes Payables tumbled by 84.44% in 2024 and then soared by 348.07% in 2025.
- China Pharma Holdings' Notes Payables (Quarterly) stood at $1.2 million in 2021, then spiked by 222.25% to $3.8 million in 2022, then tumbled by 70.16% to $1.1 million in 2023, then rose by 0.99% to $1.1 million in 2024, then surged by 348.07% to $1.4 million in 2025.
- Its Notes Payables was $1.4 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.2 million in Q1 2025.